Cargando…

Prostate Cancer Screening with PSA: Ten Years’ Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania

The aim of this study is to report key performance estimates from the ten years of a population-based prostate cancer screening programme in Lithuania. Retrospective analysis of screening activities recorded in 2006–2015 among men aged 50–74 years was performed. We estimated screening coverage, canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Patasius, Ausvydas, Krilaviciute, Agne, Smailyte, Giedre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760278/
https://www.ncbi.nlm.nih.gov/pubmed/33255919
http://dx.doi.org/10.3390/jcm9123826
_version_ 1783627295194349568
author Patasius, Ausvydas
Krilaviciute, Agne
Smailyte, Giedre
author_facet Patasius, Ausvydas
Krilaviciute, Agne
Smailyte, Giedre
author_sort Patasius, Ausvydas
collection PubMed
description The aim of this study is to report key performance estimates from the ten years of a population-based prostate cancer screening programme in Lithuania. Retrospective analysis of screening activities recorded in 2006–2015 among men aged 50–74 years was performed. We estimated screening coverage, cancer detection rate, compliance to biopsy, and positive predictive values in each screening round inside and outside the target population. In the first 10 years of screening, 16,061 prostate cancer cases were registered within the screening programme, 10,202 were observed among screened men but reported outside the screening programme, and 1455 prostate cancers were observed in a screening-naïve population. Screening cover reached up to 45.5% of the target population in the recent rounds. The proportion of prostate specific antigen (PSA) test-positive men decreased from 16.9% in 2006 to 10.7% in 2014–2015. Up to 40.0% of PSA test-positive men received a biopsy, of whom 42.0% were positive for prostate cancer. The cancer detection rate was 10.4−15.0% among PSA test-positives and 1.4–1.9% among screened individuals. Screening participants were more likely to be diagnosed with organ-confined disease as compared to non-participants. Despite the unorganized screening practices being employed and low coverage per screening round, 70% of the target population were screened at least once in the first 10 years of screening.
format Online
Article
Text
id pubmed-7760278
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77602782020-12-26 Prostate Cancer Screening with PSA: Ten Years’ Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania Patasius, Ausvydas Krilaviciute, Agne Smailyte, Giedre J Clin Med Article The aim of this study is to report key performance estimates from the ten years of a population-based prostate cancer screening programme in Lithuania. Retrospective analysis of screening activities recorded in 2006–2015 among men aged 50–74 years was performed. We estimated screening coverage, cancer detection rate, compliance to biopsy, and positive predictive values in each screening round inside and outside the target population. In the first 10 years of screening, 16,061 prostate cancer cases were registered within the screening programme, 10,202 were observed among screened men but reported outside the screening programme, and 1455 prostate cancers were observed in a screening-naïve population. Screening cover reached up to 45.5% of the target population in the recent rounds. The proportion of prostate specific antigen (PSA) test-positive men decreased from 16.9% in 2006 to 10.7% in 2014–2015. Up to 40.0% of PSA test-positive men received a biopsy, of whom 42.0% were positive for prostate cancer. The cancer detection rate was 10.4−15.0% among PSA test-positives and 1.4–1.9% among screened individuals. Screening participants were more likely to be diagnosed with organ-confined disease as compared to non-participants. Despite the unorganized screening practices being employed and low coverage per screening round, 70% of the target population were screened at least once in the first 10 years of screening. MDPI 2020-11-26 /pmc/articles/PMC7760278/ /pubmed/33255919 http://dx.doi.org/10.3390/jcm9123826 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Patasius, Ausvydas
Krilaviciute, Agne
Smailyte, Giedre
Prostate Cancer Screening with PSA: Ten Years’ Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania
title Prostate Cancer Screening with PSA: Ten Years’ Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania
title_full Prostate Cancer Screening with PSA: Ten Years’ Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania
title_fullStr Prostate Cancer Screening with PSA: Ten Years’ Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania
title_full_unstemmed Prostate Cancer Screening with PSA: Ten Years’ Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania
title_short Prostate Cancer Screening with PSA: Ten Years’ Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania
title_sort prostate cancer screening with psa: ten years’ experience of population based early prostate cancer detection programme in lithuania
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760278/
https://www.ncbi.nlm.nih.gov/pubmed/33255919
http://dx.doi.org/10.3390/jcm9123826
work_keys_str_mv AT patasiusausvydas prostatecancerscreeningwithpsatenyearsexperienceofpopulationbasedearlyprostatecancerdetectionprogrammeinlithuania
AT krilaviciuteagne prostatecancerscreeningwithpsatenyearsexperienceofpopulationbasedearlyprostatecancerdetectionprogrammeinlithuania
AT smailytegiedre prostatecancerscreeningwithpsatenyearsexperienceofpopulationbasedearlyprostatecancerdetectionprogrammeinlithuania